Microvessel density as a prognostic factor in non-small-cell lung carcinoma: a meta-analysis of individual patient data (Q31113128)

28 June 2017

0 references

Microvessel density as a prognostic factor in non-small-cell lung carcinoma: a meta-analysis of individual patient data (English)

1 reference

non-small-cell lung carcinoma

28 June 2017

1 reference

1 reference

1 reference

1 reference

1 reference

5

Douglas G Altman

1 reference

28 June 2017

Marialena Trivella

1

0 references

Ugo Pastorino

object named as

Ugo Pastorino

3

0 references

Adrian Harris

object named as

Adrian L Harris

4

0 references

author name string

Francesco Pezzella

2

1 reference

28 June 2017

Prognosis In Lung Cancer (PILC) Collaborative Study Group

6

1 reference

28 June 2017

publication date

1 June 2007

1 reference

Lancet Oncology Commission

28 June 2017

published in

1 reference

28 June 2017

volume

8

1 reference

28 June 2017

issue

6

1 reference

28 June 2017

page(s)

488-499

1 reference

Assessing prognosis in non-small-cell lung cancer: avenues to a more complete picture?

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

The surgical management of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Primer: an evidence-based approach to prognostic markers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Systematic reviews of evaluations of prognostic variables

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Systematic reviews of published evidence: miracles or minefields?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Suboptimal analysis using 'optimal' cutpoints

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Dangers of using "optimal" cutpoints in the evaluation of prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Publication Bias: A Problem in Interpreting Medical Data

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Is there publication bias in the reporting of cancer risk in Barrett's esophagus?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Selective reporting biases in cancer prognostic factor studies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

A systematic review of molecular and biological tumor markers in neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Methodological challenges in the evaluation of prognostic factors in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Prognostic significance of platelet and microvessel counts in operable non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Prognostic and predictive value of intratumoral microvessels density in operable non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

PROGNOSTIC VALUE OF ANGIOGENESIS IN OPERABLE NON-SMALL CELL LUNG CANCER

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Immunocytochemical markers in stage I lung cancer: relevance to prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Angiogenesis as a Prognostic Indicator of Survival in Non-Small-Cell Lung Carcinoma: a Prospective Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Tumor angiogenesis in human lung adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Tumour infiltrating lymphocytes in relation to tumour angiogenesis, apoptosis and prognosis in patients with large cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Relationship between vascularity, age and survival in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Patterns of angiogenesis in nonsmall-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Dichotomizing continuous predictors in multiple regression: a bad idea

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Do molecular markers predict survival in non-small-cell lung cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Angiogenesis as a predictor of survival after surgical resection for stage I non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Statistical aspects of prognostic factor studies in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Using observational data to estimate prognosis: an example using a coronary artery disease registry

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Assessing the clinical impact of prognostic factors: when is "statistically significant" clinically useful?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

A methodological appraisal of research on prognosis after transient ischemic attacks

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

When is a prognostic factor useful? A guide for the perplexed

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Meta-analyses based on abstracted data: a step in the right direction, but only a first step.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

A systematic review of molecular and biological markers in tumours of the Ewing's sarcoma family.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Individual patient-versus literature-based meta-analysis of survival data: time to event and event rate at a particular time can make a difference, an example based on head and neck cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Individual patient data meta-analysis in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Meta-analysis of the literature or of individual patient data: is there a difference?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

A comparison of meta-analytic results using literature vs individual patient data. Paternal cell immunization for recurrent miscarriage

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Preoperative radiotherapy in esophageal carcinoma: a meta-analysis using individual patient data (Oesophageal Cancer Collaborative Group).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

P53 as a prognostic marker for bladder cancer: a meta-analysis and review.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Publication bias in clinical research

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

REporting recommendations for tumour MARKer prognostic studies (REMARK)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

The International Bladder Cancer Bank: proposal for a new study concept

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Vascular endothelial growth factor expression and neovascularisation in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Tumor angiogenesis as a prognostic marker in operable non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Tumor angiogenesis and biologic markers in resected stage I NSCLC

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Tumor angiogenesis of non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Tumor angiogenesis and recurrence in stage I non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Quantification of angiogenesis as a prognostic marker in human carcinomas: a critical evaluation of histopathological methods for estimation of vascular density

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Reproducibility of microvessel counts in breast cancer specimens

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Examining the technique of angiogenesis assessment in invasive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Comparison of methods of microvascular staining and quantification in prostate carcinoma: relevance to prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Aggregate data meta-analysis with time-to-event outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

Estimating number of events from the Kaplan-Meier curve for incorporation in a literature-based meta-analysis: what you don't see you can't get!

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

4-year mortality in patients with non-small-cell lung cancer: development and validation of a prognostic index

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970145-6

7 January 2021

10.1016/S1470-2045(07)70145-6

Identifiers

DOI

1 reference

28 June 2017

1 reference